SCHEMBL6436313

SCHEMBL6436313

CCC(CO)C(O)CC(C)C

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56
TSHR P16473 2/20 0.38
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9272640 0.87 TSHR (0.44) LMNATSHRTDP1
SCHEMBL17464894 0.86 LMNA (0.46) LMNATSHRTDP1
SCHEMBL16207737 0.84 TSHR (0.42) LMNATSHRTDP1
SCHEMBL497879 0.83 LMNA (0.60) LMNATSHRTDP1
SCHEMBL3671978 0.81 LMNA (0.52) LMNATSHRTDP1
SCHEMBL2024839 0.80 LMNA (0.44) LMNATSHRTDP1
SCHEMBL1614311 0.79 LMNA (0.42) LMNATSHRTDP1
SCHEMBL17464917 0.79 LMNA (0.42) LMNATSHRTDP1
SCHEMBL940428 0.78
SCHEMBL155021 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001072866-A1 POLYURETHANE PREPARED FROM SORBITOL-BRANCHED POLYESTERS CROMPTON CORPORATION (US) 2001-10-04 WO claimed
US-20220388217-A1 MANUFACTURING METHOD FOR THERMOPLASTIC RESIN COMPOSITION, MANUFACTURING METHOD FOR SHAPED BODY, AND FILM KANEKA CORPORATION (JP) 2022-12-08 US disclosed
CN-115380060-A Method for producing thermoplastic resin composition, method for producing molded article, and film 株式会社钟化 2022-11-22 CN disclosed
US-20200140702-A1 CURING AGENT FOR COATING COMPOSITION FOR FORMING SELF-RESTORABLE LAYER, COATING COMPOSITION HAVING THE SAME AND METHOD FOR COATING AUTOMOBILE EXTERIOR USING THE SAME NOROO BEE CHEMICAL CO., LTD. (KR) 2020-05-07 US disclosed
US-20170298058-A1 HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE SHIONOGI & CO (JP) 2017-10-19 US disclosed
US-9550763-B2 Heterocyclic ring and carbocyclic derivative SHIONOGI & CO., LTD. (JP) 2017-01-24 US disclosed
US-20160024072-A1 Heterocyclic Ring and Carbocyclic Derivative SHIONOGI & CO., LTD. (JP) 2016-01-28 US disclosed
EP-1115925-B1 POLYESTERS CONTAINING NEOPENTYL GLYCOL AND FIBERS FORMED THEREFROM EASTMAN CHEM CO (US) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170298058-A1 HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE P2RX3, P2RX7, P2RX2 LMNA 3635/4885TSHR 737/4885TDP1 4738/4885
US-20160024072-A1 Heterocyclic Ring and Carbocyclic Derivative P2RX3, P2RX7, P2RX2 LMNA 3635/4885TSHR 737/4885TDP1 4738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.